share_log

港股异动 | 中手游(00302)最高涨超8% 《斗破苍穹:巅峰对决》定档6月 预约数已破600万

Changes in Hong Kong stocks | China Mobile Games (00302) rose by more than 8% “Battle for the Sky: Summit Showdown” is scheduled to exceed 6 million in June

Zhitong Finance ·  Apr 30 02:55

China Mobile Games (00302) rose as high as 8%. As of press release, it had risen 6.92% to HK$1.39, with a turnover of HK$45.1137 million.

The Zhitong Finance App learned that China Mobile Games (00302) rose by more than 8%. As of press release, it had risen 6.92% to HK$1.39, with a turnover of HK$45.113,700.

According to news, the animation-level action mobile game “Fight Through the Sky: Summit Showdown” distributed by China Mobile Games will debut on all platforms on June 7. According to reports, since the launch of the reservation process, the number of reservations on all platforms has exceeded 6 million. In addition, the third test file for the company's Fairy Sword IP's first open world RPG “Fairy Sword World” was also quite impressive on May 31. According to SDIC Securities, the launch of the new game will boost the steady growth of the company's performance, while the company continues to deepen its global layout to maximize the commercial value of IP.

Also, on April 28, China Mobile Games and Super Gaming Group announced that they had officially reached a strategic cooperation, further strengthening the depth and breadth of cooperation between the two sides. This also means that after Mr. Jiang Yukai of Pearl River Investment Management joined the board of directors of China Mobile Games as a non-executive director, Mr. Zhu Yihang, the actual controller of Pearl River Investment Management and the chairman of Super Gaming Group, further deepened the all-round cooperation between its e-sports game pan-entertainment industry and China Mobile Games.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment